ERS/UNITE4TB webinar
27 June, 2024 | Online

13:00-14:00 CEST

Chairs: Prof. Dr Christoph Lange (Borstel, Germany); Prof. Dr Raquel Duarte (Porto, Portugal)

Speaker: Dr Gabriella Ferlazzo (Geneva, Switzerland)
Discussants: Dr Akanksha Mimi Malhotra (London, United Kingdom), Dr Olha Konstantynovska (Kharkiv, Ukraine)

Fees: Free for ERS members and non-members

Overview

Despite advancements in TB treatment, significant barriers remain that hinder effective access to essential medicines. These barriers include issues related to availability, acceptability, rational use, affordability, timely access, and geographic accessibility. Healthcare professionals, policymakers, and stakeholders need a comprehensive understanding of these dimensions to develop and implement strategies that ensure equitable access to TB care and support.

Educational aims

The aim of the webinar is to provide participants with an in-depth understanding of the various dimensions of access to medicine in the context of TB treatment, by exploring the factors of availability, acceptability, rational use, affordability, timely access, and geographic accessibility.

Topics

• Overview of access to medicine
• Dimensions of Access: Availability, Acceptability, Rational Use, Affordability, Timely and Geographic Accessibility
• Access to optimize TB Treatment

Target audience

• Healthcare Professionals
• Decision Makers
• Policy Makers
• Researchers
• TB Community

Learning outcomes

• Raise awareness on the multifaceted nature of access to TB care and support.
• Highlight the importance of each dimension in optimizing TB treatment.
• Discuss current barriers and potential solutions to improving access.
• Provide practical knowledge and strategies to enhance the availability and effectiveness of TB treatment programs.
• Foster a collaborative approach among healthcare providers, policymakers, and other stakeholders to address and overcome the challenges in accessing TB care and support.